1B1 — Hc Surgical Specialists Share Price
Last trade - 00:00- SG$55.98m
- SG$54.10m
- SG$19.38m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.68 | ||
| Price to Tang. Book | 3.44 | ||
| Price to Free Cashflow | 7.83 | ||
| Price to Sales | 2.89 | ||
| EV to EBITDA | 7.11 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 21.63% | ||
| Return on Equity | 33.37% | ||
| Operating Margin | 28.97% | ||
Financial Summary
| Year End 31st May | Unit | 2022 | 2023 | 2024 | 2025 | 2026 | 2027E | 2028E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SG$m | 19.31 | 19.08 | 18.81 | 19.11 | 19.38 | n/a | n/a | -3.67% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -5.98 | -45.24 | +10.97 | +106.15 | -19.68 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
HC Surgical Specialists Limited is a Singapore-based investment holding company. The Company, together with its subsidiaries, are engaged in providing medical services. It is primarily involved in the provision of endoscopic procedures, including gastroscopies and colonoscopies, and general surgery services, with a focus on colorectal procedures across a network of clinics located throughout Singapore. Its businesses include facilities and clinics, and specialist surgeons and general practitioners. It operates a network of clinics located throughout Singapore, in both residential areas and central areas, which are accessible to the public for consultation. Its clinics have facilities needed to perform a range of procedures on-site, including endoscopic procedures and other minor surgical services. Its subsidiaries include Heah Sieu Min (Mt E) Pte. Ltd., Heah Sieu Min (Bukit Batok) Pte. Ltd., CKH (Farrer Park) Pte. Ltd., HC (Siglap) Pte. Ltd., HC (TPY) Pte. Ltd., Malcolm Lim Pte. Ltd.
Directors
- Weng Hoe Chong NEC (57)
- Sieu Min Heah CEO (53)
- Soo Ling Ong CFO (37)
- Yuxia Ouyang COO (34)
- Kok Hoong Chia EDR (57)
- Ting Ting Cai OTH (39)
- Chye Lai Lim NED (38)
- Seng Soon Ooi NID (69)
- Last Annual
- May 31st, 2026
- Last Interim
- May 31st, 2026
- Incorporated
- September 1st, 2015
- Public Since
- November 3rd, 2016
- No. of Employees
- 18
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Singapore Exchange Securities Trading Ltd
- Shares in Issue
- 153,376,000
- Address
- 233 River Valley Road, 238291
- Web
- https://www.hcsurgicalspecialists.com/en/
- Phone
- +65 62050345
- Auditors
- BDO LLP
Latest News for 1B1
Upcoming Events for 1B1
Dividend For HCSU.SI - 0.0118 SGD
Half Year 2027 HC Surgical Specialists Ltd Earnings Release
Similar to 1B1
Alliance Healthcare
Singapore Exchange Securities Trading Ltd
Aoxin Q & M Dental
Singapore Exchange Securities Trading Ltd
Asiamedic
Singapore Exchange Securities Trading Ltd
Asia Vets Holdings
Singapore Exchange Securities Trading Ltd
Beverly Wilshire
Singapore Exchange Securities Trading Ltd
FAQ
As of Today at 03:05 UTC, shares in Hc Surgical Specialists are trading at SG$0.37. This share price information is delayed by 15 minutes.
Shares in Hc Surgical Specialists last closed at SG$0.37 and the price had moved by +2.82% over the past 365 days. In terms of relative price strength the Hc Surgical Specialists share price has underperformed the FTSE Developed Asia Pacific Index by -24.9% over the past year.
There is no consensus recommendation for this security.
Find out moreThe Hc Surgical Specialists dividend yield is 5.7% based on the trailing twelve month period.
Last year, Hc Surgical Specialists paid a total dividend of SG$0.02, and it currently has a trailing dividend yield of 5.7%.Looking ahead, shares in Hc Surgical Specialists are due to go ex-dividend on 2026-10-21 and the next dividend pay date is 2026-11-03.
Hc Surgical Specialists are due to go ex-dividend on 2026-10-21 and the next dividend pay date is 2026-11-03. The historic dividend yield on Hc Surgical Specialists shares is currently 5.7%.
To buy shares in Hc Surgical Specialists you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SG$0.37, shares in Hc Surgical Specialists had a market capitalisation of SG$55.98m.
Here are the trading details for Hc Surgical Specialists:
- Country of listing: Singapore
- Exchange: SES
- Ticker Symbol: 1B1
Based on an overall assessment of its quality, value and momentum Hc Surgical Specialists is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Hc Surgical Specialists. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -8.47%.
As of the last closing price of SG$0.37, shares in Hc Surgical Specialists were trading +0.98% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Hc Surgical Specialists PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SG$0.37.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Hc Surgical Specialists' management team is headed by:
- Weng Hoe Chong - NEC
- Sieu Min Heah - CEO
- Soo Ling Ong - CFO
- Yuxia Ouyang - COO
- Kok Hoong Chia - EDR
- Ting Ting Cai - OTH
- Chye Lai Lim - NED
- Seng Soon Ooi - NID